Legal Representation
Attorney
Daiva K. Tautvydas, Reg. No. 36,077
USPTO Deadlines
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 30, 2009 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Mar 29, 2009 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jul 15, 2008 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Jul 15, 2008 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Jul 15, 2008 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jul 8, 2008 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jul 8, 2008 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 19, 2008 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 19, 2008 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 19, 2008 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 20, 2008 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Dec 19, 2007 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 19, 2007 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 19, 2007 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 16, 2007 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 17, 2007 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 003
Cosmetic preparations, namely, preparations for the treatment of hyperfunctional facial lines, glabellar lines, frown lines, facial wrinkles, asymmetries, and defects and conditions of the human skin; and, non-medicated preparations comprising or containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and their derivatives
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Pharmaceutical preparations, namely, preparations for the treatment of hyperfunctional facial lines, glabellar lines, facial wrinkles, frown lines, asymmetries, and defects and conditions of the human skin, and for use in augmentation of soft tissue; preparations for medical use comprising or containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and their derivatives; tissue augmentation kits consisting of syringes prefilled with pharmaceutical tissue augmenting preparations for use in aesthetic medicine and dermatology
First Use Anywhere:
0
First Use in Commerce:
0
Class 041
Providing medical education classes and seminars in the fields of aesthetic medicine and dermatology
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
003
005
041